Single-Stranded DNA Aptamers Against TNF and Their Potential Applications

Shao Tao1,2,3, Pingfang Song1,2, Xiaowei Zhang1,2

  • 1Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, Portland, OR, USA.

Summary

DNA aptamers were developed to block Tumor Necrosis Factor (TNF), a key factor in autoimmune diseases. These aptamers show potential as cost-effective alternatives to current biologic drugs and for in vivo TNF detection.